Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$6.78 - $9.49 $1.07 Million - $1.5 Million
-157,608 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$5.71 - $7.19 $1.43 Million - $1.81 Million
-251,200 Reduced 61.45%
157,608 $1.07 Million
Q4 2018

Feb 13, 2019

SELL
$5.79 - $8.1 $4,029 - $5,637
-696 Reduced 0.17%
408,808 $2.46 Million
Q1 2018

May 15, 2018

BUY
$10.3 - $13.64 $4.22 Million - $5.59 Million
409,504 New
409,504 $4.22 Million

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $12.5M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.